A股異動 | 片仔癀(600436.SH)大跌7% 控股股東擬減持不超1%公司股份
格隆匯7月22日丨昨日盤中高見491.88元創歷史新高的片仔癀(600436.SH)今日低開低走,現報455元,大跌7.1%,暫成交12億元,最新市值2745億元,該股今年迄今仍累漲超70%。片仔癀昨日晚間公佈,公司控股股東九龍江集團,因自身資金需求,自公吿披露日起15個交易日後的3個月內,擬通過集中競價交易方式減持其持有的公司股份數量總計不超過目前公司總股本的1%,即不超過603.3172萬股。減持價格將根據減持實施時的市場價格確定。在上述減持計劃實施期間,如公司有送股、轉增股本、增發或配股等除權事項,九龍江集團的減持股份數將進行相應調整。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.